Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profiling of wild type, K159/298Q- and K159/298R- C/EBPα expressing mouse cells

ABSTRACT: Transcriptome profiling of wild type, K159/298Q- and K159/298R- C/EBPα expressing mouse cells

PROVIDER: PRJEB24027 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2226500.fastq.gz	Fastqsanger.gz
	ERR2226501.fastq.gz	Fastqsanger.gz
	ERR2226502.fastq.gz	Fastqsanger.gz
	ERR2226494.fastq.gz	Fastqsanger.gz
	ERR2226495.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Transcriptome profiling of wild type, K159/298Q- and K159/298R- C/EBPα expressing mouse cells

Project description:To investigate the consequences of C/EBPα-acetylation on global C/EBPα-controlled gene transcription we generated Hepa1-6 mouse hepatoma cell lines with cumate-inducible expression of wt-, K159Q/K298Q- or K159R/K298R-C/EBPα-FLAG proteins

2018-06-01 | E-MTAB-6323 | biostudies-arrayexpress

Transcriptional repression of c-Myb and GATA-2 is involved in the effects of C/EBPα in p210 BCR/ABL-expressing cells

Project description:Levels of C/EBPα are low in myeloid blast crisis (BC) of chronic myelogenous leukemia (CML) and its expression in p210BCR/ABL-expressing hematopoietic cells induces granulocytic differentiation, inhibits proliferation and suppresses leukemogenesis. To assess the mechanisms involved in these effects, C/EBPα targets were identified by microarray analyses. Upon C/EBPα activation, expression of c-Myb and GATA-2 was repressed in 32D-BCR/ABL, K562 and CML-BC primary cells but only c-Myb levels decreased slightly in CD34+ normal progenitors. The role of these two genes for the biological effects of C/EBPα was assessed by perturbing their expression in K562 cells. Expression of c-Myb blocked the proliferation inhibition and differentiation-inducing effects of C/EBPα while c-Myb siRNA treatment enhanced C/EBPα-mediated proliferation inhibition and induced changes in gene expression indicative of monocytic differentiation. GATA-2 expression suppressed the proliferation inhibitory effect of C/EBPα but blocked in part the effect on differentiation; GATA-2 siRNA treatment had no effects on C/EBPα induction of differentiation but inhibited proliferation of K562 cells, alone or upon C/EBPα activation. In summary, the effects of C/EBPα in p210BCR/ABL -expressing cells depend, in part, on transcriptional repression of c-Myb and GATA-2. Since perturbation of c-Myb and GATA-2 expression has non identical consequences for proliferation and differentiation of K562 cells, the effects of C/EBPα appear to involve different transcription-regulated targets.

2008-06-13 | GSE11766 | GEO

A C/EBPα–Wnt connection in gut homeostasis and carcinogenesis

Project description:We explored the connection between C/EBPα (CCAAT/enhancer binding protein α) and Wnt signaling in gut homeostasis and carcinogenesis. C/EBPα was expressed in human and murine intestinal epithelia in the transit amplifying region of the crypts and was absent in intestinal stem cells and Paneth cells with activated Wnt signaling. In human colorectal cancer and murine APCMin/+ polyps, C/EBPα was absent from nuclear β-catenin–positive tumor cells. In chemically induced intestinal carcinogenesis, C/EBPα KO in murine gut epithelia increased tumor volume. C/EBPα deletion extended the S-phase cell zone in intestinal organoids and activated typical proliferation gene expression signatures, including that of Wnt target genes. Genetic activation of β-catenin in organoids attenuated C/EBPα expression. Comparing gene expression of wild type and C/EBPα KO organoids by RNA sequencing aimed to identify C/EBPα dependent alterations in gene expression.

2018-12-24 | GSE123925 | GEO

Transcriptomic profiling of FDH cells expressing wild-type or Site 4 mutant IL-3 receptor

Project description:RNA was extracted after treatment of FDH cells expressing wild-type or Site 4 mutant IL-3 receptor with IL-3 and the transcriptome was characterised using RNA sequencing.

2023-06-19 | GSE141232 | GEO

RNA Seq of wild-type and VPS35-D620N-expressing SH-SY5Y cells

Project description:RNA Seq of wild-type and VPS35-D620N-expressing SH-SY5Y cells

| PRJNA480517 | ENA

RNA seq of Wild Type, PSR1-expressing plants and PINP1-silenced plants

Project description:RNA seq of Wild Type, PSR1-expressing plants and PINP1-silenced plants

| PRJNA779624 | ENA

Gene expression profiling on isogenic lines expressing wild-type and mutant forms of SMARCA2 and SMARCA4

Project description:SMARCA2 and SMARCA4 are two mutually exclusive ATPase subunits of SWI/SNF complex. SMARCA4 deficient lung cancer population selectively depend on SMARCA2 for cancer growth phenotype. Rescue experiments with ectopic expression of wild-type, bromodomain mutant and ATPase dead SMARCA2 and SMARCA4 highlight that ATPase domain is the drug target. In this study, we performed genome-wide microarray and differential gene expression profiling on isogenic lung cancer lines expressing cDNA rescue constructs for wild-type, bromodomain mutant and ATPase dead SMARCA2 and SMARCA4

2015-07-21 | GSE69088 | GEO

Transcriptomic profiling of FDH cells expressing wild-type or Site 4 mutant IL-3 receptor

Project description:Transcriptomic profiling of FDH cells expressing wild-type or Site 4 mutant IL-3 receptor

| PRJNA592897 | ENA

Transcriptome profiling of wild type and ΔabaI::Km mutant

Project description:Transcriptome profiling of wild type and ΔabaI::Km mutant

| PRJNA492802 | ENA

Transcriptome Profiling of Wild-type vs. A1CF -/- Mouse Livers

Project description:Transcriptome Profiling of Wild-type vs. A1CF -/- Mouse Livers

| PRJNA427593 | ENA